As the rise of GLP-1 weight-loss drugs begins to reshape not just waistlines, but the wider food economy, what started as a breakthrough treatment for obesity and diabetes is rapidly becoming a commoditised lifestyle trend, with implications stretching from supermarket shelves to British farmland
Published Phase 3 weight-loss results for retatrutide exceed those for tirzepatide (22.5% in SURMOUNT-1) and semaglutide (14.9% in STEP-1) at comparable timepoints
BPC-157 for Gut Healing: Stomach Ulcers, IBS, Gastritis & GERD This blog explains how BPC-157, a peptide derived from gastric juice, may promote gut healing and recovery from digestive disorders such as stomach ulcers, gastritis, IBS, leaky gut, inflammatory bowel disease, and GERD
In addition, E
These drugs are becoming more popular for people who are trying to lose weight